Global Cancer Biomarkers Market Worth $33.7 Billion By 2025: Grand View Research, Inc

Global Cancer Biomarkers Market Worth $33.7 Billion By 2025: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting
According to report published by Grand View Research, The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is projected to grow at a CAGR of 14.3 % till 2025.

The global Cancer Biomarkers Market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.

In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.

People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.

U.S. cancer biomarkers market, by application, 2014 – 2025 (USD Billion)

U.S. cancer biomarkers market, by application, 2014 - 2025 (USD Billion)

Request a Sample Copy of the Global Cancer Biomarker Market Research Report @ https://www.grandviewresearch.com/industry-analysis/cancer-biomarker-market/request/rs1

Further Key findings from the study suggest:

  • Breast cancer was the largest segment by revenue share in 2016 owing to high prevalence of this type of cancer
  • Lung cancer is estimated to be the fastest-growing type due to increasing research activities toward development of novel lung cancer biomarkers
  • Genetic biomarkers, being the highest used and easily detectable held the majority share of cancer biomarker market by biomolecule in 2016
  • However, epigenetic biomarkers are anticipated to witness lucrative growth due to increasing focus on finding the role of epigenetic modifications in cancer development
  • Cancer biomarkers are majorly used for diagnostic purpose owing to their high specificity
  • The personalized medicine segment is estimated to witness fastest CAGR of 15.0% over the forecast period
  • North America dominated in terms of revenue share in 2016 due to established R&D infrastructure and high acceptance of biomarker-based cancer testing in this region
  • Asia Pacific is anticipated to grow at a substantial growth rate till 2025 with CAGR of over 16.7%
  • Some of the major companies in the cancer biomarkers market are Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological Inc.; and Becton, Dickinson and Company
     

Global cancer biomarkers market, by biomolecule, 2016 (%)

 

Global cancer biomarkers market, by biomolecule, 2016 (%)

Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/1911/ibb

Grand View Research has segmented the cancer biomarkers market by type, biomolecule, applications, and region:

Cancer Biomarker Type Outlook (Revenue, USD Billion, 2014 – 2025)

  • Breast cancer
  • Prostate cancer
  • Colorectal cancer
  • Cervical cancer
  • Liver cancer
  • Lung cancer
  • Others

Cancer Biomarker Biomolecule Outlook (Revenue, USD Billion, 2014 – 2025)

  • Genetic Biomarkers
  • Epigenetic Biomarkers
  • Metabolic Biomarkers
  • Proteomic Biomarkers
  • Others

Cancer Biomarker Application Outlook (Revenue, USD Billion, 2014 – 2025)

  • Drug discovery and Development
  • Diagnostics
  • Personalized medicine
  • Others

Cancer Biomarker Regional Outlook (Revenue, USD Billion, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Browse Related Reports @

Genomics Market – https://www.grandviewresearch.com/industry-analysis/genomics-market

Orthobiologics Market –
https://www.grandviewresearch.com/industry-analysis/orthobiological-products-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/cancer-biomarker-market